Novel Wearable Device for Heart Failure Management

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Nov 30, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new wearable device designed to help manage heart failure, a serious condition that can lead to frequent hospital visits and can be life-threatening. The device aims to monitor patients' heart health remotely, allowing doctors to detect worsening symptoms before they become serious. This could help reduce the number of hospital readmissions for heart failure patients. The trial will compare this new device to the current best method used in hospitals to see how effective it is.

To participate in the trial, individuals must be at least 18 years old, have been diagnosed with heart failure for at least three months, and have had at least one hospital visit for heart failure in the past year. Participants should also have specific levels of certain heart-related markers in their blood. However, those with severe heart conditions, recent heart attacks, or certain infections will not be eligible. If you join the trial, you can expect to wear the device and provide feedback on its effectiveness in monitoring your heart health. This study is not yet recruiting participants, so stay tuned for updates if you're interested!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of HF ≥ 3 months
• • 2. Diagnosis of NYHA Class III HF
• • 3. Subjects with age ≥ 18 years
• • 4. At least 1 HF hospitalization within 12 months prior to enrollment
• • 5. Subjects with elevated ambulatory levels of BNP/NT-proBNP
• Exclusion Criteria:
• • 1. Subjects unable to cooperate to complete the trial.
• • 2. Subjects with severe arrhythmia.
• • 3. Subjects with cardiac shock.
• • 4. Subjects with acute myocardial infarction.
• • 5. Subjects with local skin infections and injuries in the jugular vein area
• • 6. Subjects with active uncontrolled infections
• • 7. Subjects with eGFR \< 25 mL/min/1.73m2
• • 8. Pregnant women, or women likely to undergo pregnancy
• • 9. Subjects with life expectancy less than 6 months